Vietnam produces antiviral Molnupiravir for COVID-19 treatment

VOV.VN - Three Vietnamese pharmaceutical companies have drawn up plans are in the process of producing Molnupiravir, an antiviral drug for COVID-19 treatment, according to the Ministry of Health.

Molnupiravir has been used globally for mild and asymptomatic COVID-19 patients. The medication has proved to be safe and effective at reducing the risk of hospitalization and death in people with mild to moderate patients who are at increased risk of developing severe disease.

As Molnupiravir is yet to be grated a circulation registration number in Vietnam, the Ministry of Health is requesting the Government to approve the medication for emergency use in the country. If approved by the Government, three local pharmaceutical companies are expected to get the nod to produce Molnupiravir  in Vietnam.

Since late August, the Ministry of Health has implemented a pilot scheme to use Molnupiravir for mild and asymptomatic cases at home. The scheme was first deployed in Ho Chi Minh City and has so far been replicated 34 cities and provinces.